Abstract
Objectives. Human Granulocytic Ehrlichiosis (HGE) is a recently discovered zoonosis and, in
Europe, not always included in laboratory testing when a patient presents with a history
of tick bite. The available serology results indicate that HGE should be included
in the screening panel when a tick-borne disease is suspected.
Methods. Serological methods were applied; i.e. indirect immunofluorescence and Western Blot
analysis. Sixty-five serum samples from 47 patients were analysed, of six patients
sequential samples were available.
Results. 33.8% of the submitted samples were found positive in indirect immunofluorescence,
Western Blot confirmed 46.1% of these positive samples.
Conclusions. Although the causative agent and the vector for HGE, Ixodes ticks, are present in Belgium, serology for HGE is seldom solicited. Ehrlichiosis
is apparently not always considered as a plausible or possible cause for illness,
even when the patient presents with a history of tick bite. We present here a, true
be it, incomplete picture of the present situation in Belgium, but nevertheless indicating
that it is warranted to test patients with a history of tick bite not only for Lyme
disease, but also for HGE.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of InfectionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Human granulocytic ehrlichiosis.Clin Infect Dis. 2000; 31: 554-560
- Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.J Clin Microbiol. 1994; 32: 589-595
- Identification of the antigenic constituents of Ehrlichia chaffeensis.Am J Trop Med Hyg. 1994; 50: 52-58
- Ehrlichiosis in Belgium.Lancet. 1995; 346: 1233-1234
- Seroprevalence of human granulocytic ehrlichiosis infection in Belgium.Eur J Clin Microbiol Infect Dis. 2002; 21: 397-400
- Human granulocytic ehrlichiosis as a common cause of tick-associated fever in Southeast Sweden: report from a prospective clinical study.Scand J Infect Dis. 2002; 34: 187-191
- Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin.Clin Infect Dis. 1999; 29: 1472-1477
- The serological response of patients infected with the agent of human granulocytic ehrlichiosis.Clin Infect Dis. 2002; 34: 22-27
- Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark.Scand J Infect Dis. 2001; 33: 206-210
- Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents.J Clin Microbiol. 2001; 39: 3982-3986
- Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank 1 genes of Ehrlichia phagocytophila-group ehrlichiae.J Clin Microbiol. 2000; 38: 354-356
- Outcomes of treated human granulocytic ehrlichiosis cases.Emerg Infect Dis. 2002; 8: 398-401
- Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.J Clin Microbiol. 1995; 33: 1098-1103
Ducoffre G. Surveillance van Infectieuze Aandoeningen door een Netwerk van Laboratoria voor Microbiologie. Epidemiologische Trends 1983–1999. Scientific Institute of Public Health (IPH), Department of Epidemiology–Toxicology, Section Epidemiology. http://www.iph.fgov.be/epidemio, (2002).
Article info
Identification
Copyright
© 2003 The British Infection Society. Published by Elsevier Inc. All rights reserved.
